Search
Statistics
We have 222 registered usersThe newest registered user is raheelmemon
Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
Q: Antipsychotic Induced Weight Gain & Amenorrhea in First Episode Schizophrenia
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Q: Antipsychotic Induced Weight Gain & Amenorrhea in First Episode Schizophrenia
Q. Which Medication has shown to be Effective in Antipsychotic Induced Weight Gain & Amenorrhea in Patients with First Episode Schizophrenia?
(a) Fluoxetine
(b) Metformin
(c) Rosiglitazone
(d) Orlistat
Answer with Explanation will be posted soon. Everyone is encouraged to try.
(a) Fluoxetine
(b) Metformin
(c) Rosiglitazone
(d) Orlistat
Answer with Explanation will be posted soon. Everyone is encouraged to try.
Re: Q: Antipsychotic Induced Weight Gain & Amenorrhea in First Episode Schizophrenia
Admin wrote: Q. Which Medication has shown to be Effective in Antipsychotic Induced Weight Gain & Amenorrhea in Patients with First Episode Schizophrenia?
(a) Fluoxetine
(b) Metformin
(c) Rosiglitazone
(d) Orlistat
Answer with Explanation will be posted soon. Everyone is encouraged to try.
Ans: B (Metformin)
Two articles are published on this topic this month.
(1) American Journal of Psychiatry
Am J Psychiatry 2012;169:813-821.
Metformin for Treatment of Antipsychotic-Induced Amenorrhea and Weight Gain in Women With First-Episode Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Study
Results: Metformin was effective in reversing antipsychotic-induced adverse events, including restoration of menstruation, promotion of weight loss, and improvement in insulin resistance in female patients with schizophrenia.
(2) Annals of Clinical Psychiatry
Ann Clin Psychiatry. 2012 Aug;24(3):225-39.
Second-generation antipsychotic use in schizophrenia and associated weight gain: A critical review and meta-analysis of behavioral and pharmacologic treatments.
Results: Although several adjunctive pharmacologic treatments showed no weight loss, sibutramine, metformin, and topiramate showed some benefit. Amantadine and orlistat were somewhat less effective and had lower rates of tolerability. Among the behavioral therapies, nutritional counseling combined with exercise showed the most benefit. Behavioral therapies, although modest, showed the most consistent benefits compared with controls.
Similar topics
» Association of Weight Gain and Metabolic Syndrome in Patients Taking Clozapine
» Normalization of Risperidone-Induced Hyperprolactinemia with the Addition of Aripiprazole
» Which Antipsychotic is Most Likely to cause Decreased Prolactin?
» An Algorithm-Based Approach to First-Episode Schizophrenia
» FDA Approves Inhaled Antipsychotic (Loxapine)
» Normalization of Risperidone-Induced Hyperprolactinemia with the Addition of Aripiprazole
» Which Antipsychotic is Most Likely to cause Decreased Prolactin?
» An Algorithm-Based Approach to First-Episode Schizophrenia
» FDA Approves Inhaled Antipsychotic (Loxapine)
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
Sat Sep 10, 2016 1:45 pm by Admin
» L-Methylfolate: Who Will benefit
Sat Sep 03, 2016 3:00 pm by Admin
» Vitamins & Supplements in Clinical Practice.
Sun Aug 21, 2016 12:27 pm by Admin
» Imaging Biomarkers for Outcomes in Mild TBI
Fri Jul 22, 2016 12:37 pm by Admin
» Q.5 Clozapine Neutopenia
Mon Jul 11, 2016 8:43 pm by Admin
» Treating Disorders!
Mon Jul 04, 2016 1:52 am by troymackys
» Cortical Abnormalities in Adults & Adolescents with MDD
Sun Jul 03, 2016 12:59 pm by Admin
» Efficacy of Antipsychotics in Pediatric Acute Mania
Wed Jun 22, 2016 8:46 pm by Admin
» Obsessive Compulsive Disorder in Adults: Which Treatment is Better?
Tue Jun 21, 2016 9:34 pm by Admin